Xiao‐Feng Le

3.3k citations
51 papers · 2.7k · h-index 33

Impact in

    • MicroRNA in disease regulation
  • Oncology top 5%
    • HER2/EGFR in Cancer Research
    • Cancer-related Molecular Pathways

Papers in

    • HER2/EGFR in Cancer Research 9
    • Cancer-related Molecular Pathways 3
    • MicroRNA in disease regulation 4

Xiao‐Feng Le

51 papers receiving 2.6k citations

Peers

Xiao‐Feng Le
Comparison fields: 5 of 90
  • Cancer Research 537
  • Oncology 580
  • Reproductive Medicine 174
  • Molecular Biology 730
  • Cell Biology 97
Replace Yi Huang with:
Yi Huang China
Makoto Saegusa Japan
Sarah R. Walker United States
Akiteru Goto Japan
Bettina C. Couderc France
Qingchang Li China
Go J. Yoshida Japan
Rafał Matkowski Poland
Yongchang Chen China
Xiangdong Le United States
Xiao‐Feng Le relative to Yi Huang China Yi Huang's profile →
Citations per field
00.5×1.5×2×2.5×
Yi Huang · 1×
Citations per year

Countries citing papers authored by Xiao‐Feng Le

Since Specialization
Citations

This map shows the geographic impact of Xiao‐Feng Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Feng Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Feng Le more than expected).

Fields of papers citing papers by Xiao‐Feng Le

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao‐Feng Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Feng Le. The network helps show where Xiao‐Feng Le may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiao‐Feng Le, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiao‐Feng Le Line = papers co-authored together Xiao‐Feng Le links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2011244
2 2003126
3 2004122
4 2010121
5 1996116
6 2018105
7 201291
8 199889
9 201480
10 201079
11 201079
12 201170
13 201164
14
Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway.
200263
15 201261
16 201961
17 200458
18
The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression.
199957
19 201257
20 200355

About Xiao‐Feng Le

Xiao‐Feng Le is a scholar working on Oncology, Cancer Research, Reproductive Medicine, Cell Biology and Molecular Biology, having authored 51 papers that have together received 2.7k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Spinal Fractures and Fixation Techniques (7 papers), Ovarian cancer diagnosis and treatment (6 papers), Microtubule and mitosis dynamics (4 papers), MicroRNA in disease regulation (4 papers), Cancer-related Molecular Pathways (3 papers), Retinoids in leukemia and cellular processes (3 papers) and Cell death mechanisms and regulation (3 papers). The work is most often cited by research in Cancer Research (537 citations), Oncology (580 citations), Reproductive Medicine (174 citations), Molecular Biology (730 citations) and Cell Biology (97 citations). Xiao‐Feng Le has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Robert C. Bast, Kun-Sang Chang, Weiqun Mao, George A. Călin, Zhen Lü, Peirong Yang, Gordon Brent Mills, Any Cheung, Wei Tian and Hys Ngan. Their work appears in journals such as Journal of Biological Chemistry, Clinical Cancer Research, PLoS ONE, Cancer and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact